B Value

AI Verified

Location

Germany


Investor type

Venture Capital


Current investment status

00 00 00


Website

https://bvalue.de


Linkedin

00 00 00


Submission link

00 00 00


Company address

BioMedizinZentrum (BMZ), 15, Otto-Hahn-Straße, Studentendorf Dortmund, Eichlinghofen, Hombruch, Dortmund, North Rhine-Westphalia, 44227, Germany


Founding year

N.A.


Twitter

00 00 00


Facebook

00 00 00

Criteria Requirements Match
Regions Eastern Europe, Western Europe
00
Countries
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Sector
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Impact Area
00 00 00
Stage Seed, Series A, Growth Stage, Pre-Seed
00
Ticket size
00 00 00
-
00 00 00
USD
00
Monetization model
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Product readiness
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Client types
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Min. revenue
00 00 00
USD
00
Other
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
-

Unlock Free Premium Insights

Discover how well you match with this investor and reach out on the Raise Better platform.

  • Advanced matching algorithm
  • Detailed compatibility scores
  • Priority investor access
Create Free Account

Company description

B Value AG positions itself at the forefront of sustainable innovation, focusing on transformative advancements in biotechnology and advanced materials sectors. The firm strategically invests in technologies that enable environmentally conscious processes and products, recognizing these as foundational elements for future sustainability. Their investment scope encompasses diverse cutting-edge fields including precision fermentation, life science instrumentation, eco-friendly chemical development, and next-generation materials science. Rather than merely following industry trajectories, B Value seeks visionary entrepreneurs developing proprietary technologies with the potential to revolutionize established markets and create entirely new commercial opportunities.

What distinguishes B Value from traditional venture capital firms is their hands-on investment approach powered by a multidisciplinary team with substantial scientific backgrounds, entrepreneurial experience, and venture development expertise. This practical knowledge allows them to provide portfolio companies with guidance that extends far beyond financial support. Their unconventional fund architecture enables exceptional flexibility in investment decisions and facilitates long-term partnerships with portfolio companies, avoiding the typical pressure for premature exits that often characterizes venture capital relationships. B Value positions itself as an active collaborator rather than a passive investor, working alongside founders to transform scientific breakthroughs into commercially viable enterprises.

The firm has cultivated a reputation for identifying and nurturing disruptive technologies with significant market potential. Their portfolio showcases companies developing solutions across the bioeconomy spectrum, from synthetic biology platforms to advanced biomaterials and sustainable chemical processes. B Value typically engages with companies from early development stages through growth phases, providing continuous support throughout the challenging commercialization journey. Their investment thesis centers on backing technologies that not only promise substantial financial returns but also contribute meaningfully to addressing global sustainability challenges.

B Value maintains a global perspective while leveraging strong European connections, particularly within the DACH region's robust scientific and industrial ecosystem. They actively seek partnerships with founders who demonstrate both scientific excellence and commercial acumen, valuing teams that combine technical innovation with market awareness. The firm's investment strategy prioritizes scalable business models built around defensible intellectual property that can create significant competitive advantages. For entrepreneurs developing potentially industry-defining biotechnology or materials science innovations, B Value offers not just capital but a comprehensive partnership designed to navigate the complex journey from laboratory discovery to market leadership.

Highlights

Backing biotech innovations that redefine industries
Beyond capital: Hands-on support for visionary founders

Ready to raise better?

Create your Free Account!

Frequently asked questions

Where is B Value located?

B Value maintains its global headquarters in Germany, serving as the strategic center for its operations. The company's primary corporate offices are located at BioMedizinZentrum (BMZ), 15, Otto-Hahn-Straße, Studentendorf Dortmund, Eichlinghofen, Hombruch, Dortmund, North Rhine-Westphalia, 44227, Germany.

What investment stages B Value focuses on?

B Value focuses its investment activities on companies operating in the following stages: Seed, Series A, Growth Stage, Pre-Seed. B Value provides strategic capital and expertise to support promising businesses at these critical phases of development.

Where does B Value invest?

B Value maintains a strategic global investment presence, actively seeking opportunities across the following key regions: Eastern Europe, Western Europe.

When was B Value founded?

B Value was established in , marking the beginning of its journey as an investment firm.

What kind of investment firm is B Value?

B Value is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.